Chen H et al. demonstrated that Nuclear factor I/B (NFIB) was upregulated in ER+ breast cancer versus normal tissue and that NFIB promoted MCF-7 cell cycle progression and proliferation in in vitro experiments. Here, ESR1 is linked to breast carcinoma.